PROSPECT: Observational, descriptive study of PRior and concomitant psoriasis treatments in patients receiving Secukinumab in the routine treatment of moderate to severe plaque-type psoriasiss

19/08/2015
02/07/2024
EU PAS number:
EUPAS10715
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

PROSPECT-NIS Protocol Final Redacted 2015-06-18

English (440.79 KB - PDF) View document
Updated protocol

CAIN457ADE07_PROSPECT-NIS_Protocol_Am1_2016-05-13_clean_redacted

First published: 22/02/2024
English (441.8 KB - PDF) View document
Study results
Study results

CAIN457ADE07 _final CSR_report_V1.0_190131_2_Redacted

English (803.85 KB - PDF) View document
Study report
Other information